Parabilis Medicines, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| – | -45.9% | |
| – | -68.2% | |
| – | -41.4% | |
| – | -68.5% | |
| – | – | |
| – | +4.9% | |
| – | +75.2% | |
| – | +122.8% | |
| – | +81.5% | |
| – | – | |
| – | -129.3% | |
| – | – | |
| – | +4.6% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.